Prognostic significance of blood-based PD-L1 analysis in patients with non-small cell lung cancer undergoing immune checkpoint inhibitor therapy: a systematic review and meta-analysis

BACKGROUND: The main types of PD-L1 in the blood include soluble PD-L1 (sPD-L1), exosomal PD-L1 (exoPD-L1), and PD-L1 in circulating tumor cells (CTCs). However, the predictive and prognostic values of these three indicators in patients with non-small cell lung cancer (NSCLC) undergoing immune check...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Qian, Li, Wentao, Wang, Dong, Wang, Shuangcui, Yu, Jianchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566159/
https://www.ncbi.nlm.nih.gov/pubmed/37821941
http://dx.doi.org/10.1186/s12957-023-03215-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566159/
https://www.ncbi.nlm.nih.gov/pubmed/37821941
http://dx.doi.org/10.1186/s12957-023-03215-2

Ejemplares similares